SCHEMBL16456285

SCHEMBL16456285

N#Cc1ccc2c(c1)c1cc(-c3c4ccccc4c(Br)c4ccccc34)ccc1n2-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ G6PD P11413 2/20 0.38
▸ TDP2 O95551 3/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ PGR P06401 1/20 0.34
▸ PTGER4 P35408 1/20 0.34
▸ FASN P49327 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ ACLY P53396 1/20 0.32
▸ USP14 P54578 1/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ DRD4 P21917 1/20 0.32
▸ DRD3 P35462 1/20 0.32
▸ EGFR P00533 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16809525 0.91 KDM4E (0.42) KDM4EATML3MBTL1G6PDTDP2
SCHEMBL16548674 0.90 KDM4E (0.41) KDM4EATML3MBTL1G6PDTDP2
SCHEMBL16455825 0.89 ATM (0.38) KDM4EATML3MBTL1G6PDTDP2
SCHEMBL16557905 0.87 DPP4 (0.39) KDM4EATML3MBTL1G6PDTDP2
SCHEMBL16548678 0.87 KDM4E (0.39) KDM4EATML3MBTL1G6PDTDP2
SCHEMBL16455817 0.87 CA1 (0.37) KDM4ETDP2PGRPTGER4CA1
SCHEMBL15250617 0.86 G6PD (0.44) KDM4EATML3MBTL1G6PDTDP2
SCHEMBL15250627 0.86 G6PD (0.44) KDM4EATML3MBTL1G6PDTDP2
SCHEMBL16557994 0.86 DPP4 (0.39) KDM4EATML3MBTL1G6PDKMT2A
SCHEMBL16549020 0.86 KDM4E (0.38) KDM4EATML3MBTL1G6PDTDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 — — US disclosed
US-9583715-B2 Anthracene-based compounds and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-02-28 — — US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 — — US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 — — US disclosed
US-20150041773-A1 ANTHRACENE-BASED COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-02-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 KDM4E 3143/4885ATM 1334/4885L3MBTL1 1123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback